Tag: somatostatin analog therapy
DENIED: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment
June 8, 2015
The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…
READ MORE
Discover Something New in Carcinoid Syndrome
November 11, 2013
For patients who suffer from carcinoid syndrome – with symptoms such as diarrhea, frequent bowel movements, abdominal pain, and flushing – that is not adequately controlled by their current somatostatin analog therapy, there is an opportunity to participate…
READ MORE
